01. Edit your patient prescriber agreement online
Type text, add images, blackout confidential details, add comments, highlights and more.
Patient-Prescriber Agreement Form - TIRF REMS 2026
Here's how it works
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send patient prescriber agreement form via email, link, or fax. You can also download it, export it or print it out.
How to use or fill out Patient-Prescriber Agreement Form - TIRF REMS with DocHub
Ease of Setup
DocHub User Ratings on G2
Ease of Use
DocHub User Ratings on G2
- Click ‘Get Form’ to open the Patient-Prescriber Agreement Form in our editor.
- Begin by filling out the prescriber section. Enter your first and last name, DEA number, National Provider Identifier (NPI), and fax number. Ensure all required fields are completed.
- Review the acknowledgment statements regarding TIRF medicines carefully. Check each box to confirm your understanding of the risks and responsibilities associated with prescribing TIRF medications.
- Next, move to the patient section. The patient or their representative should provide their signature, name, date of birth, and contact information. Make sure all required fields are filled out accurately.
- Once all sections are complete, review the entire form for accuracy. Use our platform’s tools to make any necessary edits before finalizing.
- Finally, save your completed form and choose to either print it for fax submission or share it directly via email if needed.
Start using our platform today to streamline your document editing and signing process for free!
What is the purpose of the REMS program?
A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the U.S. Food and Drug Administration (FDA) can require for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks.
What does tirf mean in medical terms?
TIRF (transmucosal immediate-release fentanyl) medicines contain fentanyl, a prescription opioid pain reliever. TIRF medicines are used to manage breakthrough pain in adults with cancer who are routinely taking other opioid pain medicines around-the-clock for pain.
What is the Tirf rems program?
The Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) Program is an FDA-required program designed to ensure informed risk-benefit decisions before initiating treatment, and while patients are treated to ensure appropriate use of TIRF medicines.
What is the purpose of the Tirf program?
The purpose of the TIRF REMS Access program is to mitigate the risk of misuse, abuse, addiction, overdose and serious complications due to medication errors with the use of TIRF medicines.
Security and compliance
At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.
fda drug authority
Sep 25, 2013 Patient-Prescriber Agreement Form (PPAF), Patient. Enrollment Form, REMS-dedicated Website. Prescriber directed tools have included REMSRead more
Jun 1, 2012 This memo serves as documentation of agreement between OSE/DRISK and the sponsors of the. TIRF REMS Access program for the first modification ofRead more